Pfiz­er, Gates Foun­da­tion and oth­ers plan to boost pro­duc­tion of con­tra­cep­tive Sayana Press

The Bill and Melin­da Gates Foun­da­tion is help­ing the ramp up the pro­duc­tion and avail­abil­i­ty of in­jectable con­tra­cep­tives for women in low­er- and mid­dle-in­come na­tions.

The or­ga­ni­za­tion, along with Pfiz­er, Bec­ton, Dick­in­son & Com­pa­ny, and the Chil­dren’s In­vest­ment Fund Foun­da­tion, plan to de­liv­er more than 320 mil­lion dos­es of the long-act­ing con­tra­cep­tive Sayana Press through 2030. Ac­cord­ing to a state­ment, the or­ga­ni­za­tions are up­dat­ing a pri­or part­ner­ship that start­ed in 2013 and are plan­ning to in­crease the man­u­fac­tur­ing ca­pac­i­ty for pro­duc­ing the con­tra­cep­tives.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER